BIOSCIENCE VALUATION
Our Services & Solutions
We offer all services and analytics required to evaluate life science assets.
R&D Risk Analysis / R&D Productivity Increase
Bioscience Valuation’s Assessment of R&D Strategy and Development Risk includes
- R&D risk evaluation and comparison with benchmarks,
- fine-tuning of R&D success probabilities based on
– stage of development,
– indication,
– degree of innovation,
– mode of action,
– type of molecule,
- optimization of the development plan using decision trees, comparison with alternative development scenarios,
- calculation of expected value jumps once development milestones have been reached,
- applying the ‘value of perfect information’ algorithm to inform investment decisions.
R&D productivity can be increased by
- comprehensive target validation,
- enhanced statistical power of preclinical research,
- improved clinical trial funding, risk-sharing agreements,
- optimization of clinical design,
- considering insights gained from real world evidence (e.g., patient reported outcomes),
- engagement in personalized medicine.